WallStreetZenWallStreetZen

NASDAQ: NBP
Novabridge Biosciences Stock Ownership - Who owns Novabridge Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Novabridge Biosciences insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cong Claire XuSVP Clinical Development2026-07-064,485$0.89
$3.99kSell
Phillip Andrew DennisChief Medical Officer2026-06-188,494$0.66
$5.61kSell
Cong Claire XuSVP Clinical Development2026-06-013,494$3.94
$13.77kSell
Sean Wuxiong CaoChief Business Development Officer and Director2026-05-1421,399$1.99
$42.58kSell
Mark Arnold HaglerPresident and Chief Commercial Officer2026-04-24230,000$2.51
$577.30kBuy

1 of 1

NBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBP insiders and whales buy or sell their stock.

NBP Shareholders

What type of owners hold Novabridge Biosciences stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wei Fu11.49%30,499,699$49.10MInsider
Janus Henderson Group PLC2.27%6,032,650$9.71MInstitution
Hhlr Advisors Ltd2.25%5,980,568$9.63MInstitution
Morgan Stanley1.45%3,838,198$6.18MInstitution
Siren LLC1.13%3,000,000$4.83MInstitution
Aihc Capital Management Ltd0.85%2,262,933$3.64MInstitution
Point72 Asset Management LP0.52%1,389,403$2.24MInstitution
Candriam Sca0.43%1,132,563$1.82MInstitution
Adage Capital Partners GP LLC0.38%1,000,000$1.61MInstitution
Xiaofan Neo Zhang0.33%874,000$1.41MInsider

1 of 3

NBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBP11.05%12.12%Net BuyingNet Selling
PLX10.86%89.14%Net Buying
IMUX80.09%19.91%
VYGR53.04%46.96%Net Selling
NERV53.55%46.45%
View Top Biotech Stocks

Novabridge Biosciences Stock Ownership FAQ

Who owns Novabridge Biosciences?

Novabridge Biosciences (NASDAQ: NBP) is owned by 11.05% institutional shareholders, 12.12% Novabridge Biosciences insiders, and 76.83% retail investors. Wei Fu is the largest individual Novabridge Biosciences shareholder, owning 30.50M shares representing 11.49% of the company. Wei Fu's Novabridge Biosciences shares are currently valued at $50.32M.

If you're new to stock investing, here's how to buy Novabridge Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.